Sign in

CIK 0001650648

  • Non-accelerated filer
  • Smaller reporting company

4D Molecular Therapeutics, Inc.

Sign in to watch
Ticker
FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473506994
Phone
+1 510-505-2680
Business address
5858 HORTON STREET #455, EMERYVILLE, CA, 94608
Former names
4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,704,701
in 6 filings, $2.7M under 10b5-1 plans

Net −$2,704,701. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kirn David −$2.7M See Remarks sold 21% of stake
  2. Bizily Scott −$51K Chief Legal Officer sold 31% of stake
Date Insider Transaction Shares Price Value Owned after
2026-03-25 Simms Christopher Paul See Remarks Grant or award · Stock Option (Right to Buy) +219,000 219,000

Page 1 of 1 · 1 trade